Sionna Therapeutics (SION) Change in Cash (2024 - 2026)
Sionna Therapeutics (SION) posted Change in Cash of $4.9 million for Q1 2026, down 36.06% sequentially from $7.6 million in Q4 2025, and down 89.15% YoY from $44.9 million in Q1 2025.
Sionna Therapeutics (SION) Change in Cash (2024 - 2026) Analysis & Trends
Sionna Therapeutics has reported Change in Cash for 3 years, with the latest figure at $4.9 million in Q1 2026.
- Quarterly Change in Cash fell 89.15% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.4 million (down 33882.46% YoY) and the FY2025 annual result came in at $20.7 million, up 2919.1% from the prior year.
- Change in Cash retreated to $4.9 million in Q1 2026 per SION's latest filing, from $7.6 million in the prior quarter.
- Over five years, Change in Cash peaked at $44.9 million in Q1 2025 and troughed at -$41.7 million in Q2 2025.
- A 3-year average of $2.8 million and a median of $4.9 million in 2026 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2025 and 2026: Change in Cash soared 273.76% in 2025, then sank 89.15% in 2026.
- Over 3 years, Change in Cash stood at $2.0 million in 2024, then jumped by 273.76% to $7.6 million in 2025, then slumped by 36.06% to $4.9 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $4.9 million, $7.6 million, and $9.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Sionna Therapeutics | 291.76 Mn | 291.76 Mn | - | -2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,000.00 |
| Mar 31, 2026 | 4.87 Mn |
| Dec 31, 2025 | 7.62 Mn |
| Sep 30, 2025 | 9.85 Mn |
| Jun 30, 2025 | -41.71 Mn |
| Mar 31, 2025 | 44.91 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Sep 30, 2024 | -8.28 Mn |
| Jun 30, 2024 | -38.73 Mn |
| Mar 31, 2024 | 44.23 Mn |